Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical Hyperplasia

Project: Research project

Project Details


NARRATIVE Women with atypical hyperplasia (AH) have increased risk of breast cancer (BC). Toward the goal of improving cancer prevention for these women, this research will identify biomarkers from breast biopsy tissues that will improve individualized risk prediction and help to determine which women will personally benefit from tamoxifen.
Effective start/end date1/1/2012/31/22


  • National Cancer Institute: $1,772,289.00
  • National Cancer Institute: $790,862.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.